1,930 research outputs found

    Ulteriori indagini sull'attività antivirale di alcuniu detergenti di sintesi

    No full text
    verrà inserito non appena le biblioteche verranno riapert

    Immunogenicity of yeast-derived hepatitis B vaccines in young adults

    No full text
    A study of the safety and immunogenicity of two different recombinant DNA yeast-derived hepatitis B vaccines was conducted in 90 young adults according to a 0-, 1-, and 6-month vaccination schedule. Preliminary results using the 20 μg SmithKline Biologicals or 10 μg Merck Sharp & Dohme recombinant yeast-derived hepatitis B vaccines indicate that both vaccines are clinically safe and immunogenic. Only minor side effects have thus far been reported. Seroconversion rates among vaccine recipients were 80% or greater after the first two injections with either vaccine, and 100% after the third dose of the SmithKline Biologicals recombinant DNA hepatitis B vaccine

    “Volumi di luce” (Opera esposta nella mostra “l’Unità dell’arte, l’arte dell’Unità. Segni contemporanei del mutamento”. Complesso dei Dioscuri del Quirinale. Roma. 2/12 settembre 2011)

    No full text
    Acquerello pubblicato in Folco G., Bergamini E., Cortese F. (a cura di), catalogo della mostra Arte contemporanea italiana. l’Unità dell’arte, l’arte dell’Unità. Segni contemporanei del mutamento -. sala Mostre del Complesso dei Dioscuri del Quirinale a Roma. 2 - 12 settembre Itala Arte Edizioni, Torino 2011

    [Update on postcoital hormonal contraception. Part 1].

    No full text
    In recent years new protocols of post-coital hormonal contraception have been devised that cause fewer side-effects. 0.2 mg ethinyl-estradiol with 2 mg norgestrel twice within 72 hours after intercourse were among the first combinations that would utilize low doses of hormones. Other authors use even smaller doses; preparations for intramuscular injection are available if the woman vomits the tablets. Progesterone has been used alone within 12 hours following intercourse with a success rate close to estrogen-progestin combinations. Quingestanol acetate is used for 5 days, 0.9-1.5 mg/day. With danazol fewer side-effects are seen; 400 mg are taken twice within 72 hours with a good rate of success
    corecore